Barnett C, Denton BT. Developing near-optimal biomarker-based prostate cancer screening strategies. Presented at the 2016 INFORMS Annual Meeting; November 14, 2016. Nashville, TN.
Yaylali E, Farnham P, Sansom S, Hicks KA, Honeycutt A, Tucker E. Using the HOPE model for evaluating HIV interventions in the US. Presented at the 2016 INFORMS Annual Meeting; November 13, 2016. Nashville, TN.
Barnett C, Merdan S. Data analytics for optimal detection of metastatic prostate cancer. Presented at the 2016 INFORMS Annual Meeting; November 13, 2016. Nashville, TN.
Boye ME, Houghton K, Stull DE. Rethinking what missing patient-reported outcome (PRO) data can teach us about outcomes and survival in oncology clinical trials. Presented at the 2016 ISPOR 19th Annual European Congress; November 1, 2016. Vienna, Austria.
Mauskopf J, Earnshaw SR, Mullins CD, Brogan A. Building a budget impact model: budget impact analysis training. Presented at the 2016 ISPOR Training Courses; November 2016. Durham, NC.
Muszbek N, Wolowacz S, Benedict A. Health economic modeling in oncology. Presented at the 2016 ISPOR 19th Annual European Congress; October 31, 2016. Vienna, Austria.
Earnshaw SR, Brogan AJ, Brodtkorb TH. Budget impact analysis II: applications & design issues. Presented at the 2016 ISPOR 19th Annual European Congress; October 30, 2016. Vienna, Austria. Previously presented at the ISPOR 20th Annual International Meeting.
Earnshaw SR, Mullins CD, Brogan AJ. Budget impact analysis I: a 6-step approach. Presented at the 2016 ISPOR 19th Annual European Congress; October 30, 2016. Vienna, Austria. Previously presented at the ISPOR 18th Annual European Congress.
Wolowacz S, Briggs A, Lloyd AJ, Doward L. Collecting health-state utility estimates for economic models in clinical studies. Presented at the 2016 ISPOR 19th Annual European Congress; October 29, 2016. Vienna, Austria.
Jacobson E, Hicks KA, Yaylali E, Chen YH, Sansom S. Effects of reaching national HIV/AIDS strategy viral load suppression goal on HIV incidence, by race and ethnicity, in the United States. Presented at the 38th Annual North American Meeting of the Society for Medical Decision Making; October 24, 2016. Vancouver, Canada.
White M, Hogue S, Odom D, Cooney D, Bartsch J, Hollis K, Herrem C, Silvia S. EPIPEN4SCHOOLS® survey combined analysis: a comprehensive assessment of anaphylaxis in US schools. Presented at the 2016 AAP National Conference & Exhibition; October 22, 2016. Sacramento, CA.
Hassmiller Lich K, Anderson S, Branscomb J, Calancie L. It's a matter of time: using trend graphs to build understanding and choose smart strategies. Presented at the 2016 Maternal and Child Health (MCH) Summer Skills Institute; August 25, 2016.
Hassmiller Lich K, Calancie L, Collins S, Anderson S, Chaudhry A, Cox S, Ewy S. Planning and supporting collaborative initiatives: using system support mapping to coordinate action. Presented at the 2016 Maternal and Child Health (MCH) Summer Skills Institute; August 23, 2016.
Anderson S, Hassmiller Lich K, Collins S, Calancie L. Expanding your thinking about sweet spots for change with the levels of leverage framework. Presented at the 2016 Maternal and Child Health (MCH) Summer Skills Institute; August 22, 2016.
Lunan M. The dynamics of nurse interaction: the use of humour in GP surgeries. Presented at the 2016 Linguistic Impoliteness, Aggression and Rudeness Conference (LIAR IV); July 12, 2016. Manchester, United Kingdom.
Campbell K, Naire S, Kuiper JH. A mathematical model of cartilage regeneration after cell therapy mediated by growth factors. Presented at the 2016 Internal Conference ‘Recent Trends of Mathematical Research’; July 2016.
Parikh R, White C, Franzini L, Taychakhoonavudh S. Size matters, quality not so much: a hospital-level analysis of commercial prices for inpatient stays in Texas. Presented at the 6th Biennial Conference of the American Society of Health Economists; June 14, 2016. Philadelphia, PA.
Blonde L, Kitio-Dschassi B, Guerci B, Meyers J, Berria R, Ajmera M, Nikonova E, Davis K, Bertolini M, Raccah D. A real-world comparison of longitudinal HbA1c and health care costs in patients receiving two oral antidiabetic therapies, GLP-1RAs, or basal insulin. Presented at the 76th American Diabetes Association (ADA) Scientifc Sessions; June 13, 2016. New Orleans, LA.
Ensor CR, Harrigan (Zhang) K, Venkataramanan R, Morrell MR, Moore CA, Hayanga JA, Crespo MM, D’Cunha J, Zeevi A, McDyer JF. Increasing tacrolimus time-in-therapeutic range is associated with less cellular rejection in lung transplant recipients. Presented at the 2016 American Transplant Congress; June 12, 2016. Boston, MA.
Mauskopf JA, Mullins CD, Earnshaw SR. Budget impact analysis I: a 6-step approach. Presented at the 2016 ISPOR 21st Annual International Meeting; May 22, 2016. Washington, DC. Previously presented at the ISPOR 18th Annual European Congress.
Earnshaw SR, Brogan A, Brodtkorb TH. Budget impact analysis II: applications & design issues. Presented at the 2016 ISPOR 21st Annual International Meeting; May 22, 2016. Washington, DC. Previously presented at the ISPOR 20th Annual International Meeting.
Lucas A. Reducing hospital census variation through rearranging surgical service blocks. Presented at the Healthcare Systems Process Improvement Conference 2016; February 19, 2016. Houston, TX.
Manga N, Oppong R, Luckraz H, Andronis L, Charman L. Comparative and concurrent methods for estimating costs: an example from a study assessing the costs of ventilator associated pneumonia. Presented at the 2016 UK Health Economists' Study Group (HESG) Meeting; January 8, 2016. Manchester, United Kingdom.
Campbell K, Naire S, Kuiper JH. A mathematical model of cartilage regeneration after cell therapy mediated by growth factors. Presented at the 2016 Faculty of Natural Sciences Annual Symposium; 2016. Previously presented at the 2016 Internal Conference ‘Recent Trends of Mathematical Research’.